4 June 2021
Assura plc
Annual Report & Notice of AGM
Assura plc ("Assura"), the leading primary care property investor and developer, is pleased to announce that the Annual General Meeting ("AGM") will be held on Tuesday 6 July 2021.
The Annual Report and Accounts for the year ended 31 March 2021 and the Notice of AGM will be posted to shareholders today.
In accordance with Listing Rule 9.6.1, copies of these documents have also been submitted to the UK Listing Authority via the National Storage Mechanism and will be available for viewing shortly at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and can also be found on the Company's website at http://assuraplc.com/investor-relations/reports-and-presentations/ .
The Board is looking forward to being able to welcome shareholders to physically attend Assura AGMs when circumstances once again permit. However, the health of the Company's shareholders, as well as its employees and customers, is of paramount importance. In light of the evolving COVID-19 situation public health concerns and the accompanying public health guidance and legislation issued by the UK Government in relation to the pandemic, and following due consideration and the guidance from the Investment Association, Quoted Companies Alliance, GC 100 and others relating to the holding of general meetings, we regret that we will be unable to allow shareholders to attend the AGM being held on Tuesday 6 July 2021 in person, and the Company will be unable to allow entry to anyone seeking to attend the AGM in person.
The AGM will address formal matters only. Following the AGM, Ed Smith (Chairman) and Jonathan Murphy (CEO) will host a Q&A for shareholders over the online Investor Meet Company platform. This will commence at 1.45pm on Tuesday 6 July and shareholders can register to attend in advance via the following link:
https://www.investormeetcompany.com/assura-plc/register-investor
Shareholders are invited to submit any questions in respect of the business of the AGM for the Board to consider. Questions may be submitted in advance over the Investor Meet Company platform following registration and the Board will aim to respond to any such questions relevant to the business of the AGM. Further information is set out in the Notice of AGM.
Shareholders wishing to vote at the AGM are strongly encouraged to do so by completing a Form of Proxy as appropriate. Shareholders will not be able to vote at the meeting over the online platform.
- ENDS -
For further information, please contact:
Assura plc: Orla Ball, Company Secretary David Purcell, Head of Investor Relations |
Tel: 01925 420 680 Email: Investor@assura.co.uk |
Finsbury: Gordon Simpson James Thompson |
Tel: 0207 251 3801 Email: Assura@Finsbury.com |
This announcement contains inside information as defined in Article 7 of the EU Market Abuse Regulation No 596/2014 and has been announced in accordance with the Company's obligations under Article 17 of that Regulation.
Notes to Editors
Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2021, Assura's property portfolio was valued at £2,453 million.
Further information is available at www.assuraplc.com
*EPRA is a registered trademark of the European Public Real Estate Association.